Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 10;18(2):e0281714. doi: 10.1371/journal.pone.0281714

Relationship between ultra-widefield optical coherence tomography and ophthalmoscopy for detecting posterior inflammation in posterior uveitis and panuveitis

Norihiko Misawa 1, Mizuki Tagami 1,*, Atsushi Sakai 1, Yusuke Haruna 1, Shigeru Honda 1
Editor: De-Kuang Hwang2
PMCID: PMC9916645  PMID: 36763630

Abstract

Purpose

To confirm the utility of ultra-widefield optical coherence tomography (W-OCT) for diagnosing uveitis.

Method

We retrospectively studied patients who had been diagnosed with uveitis and had undergone W-OCT. All patients had visited at Osaka Metropolitan University between January 2019 and January 2022. On W-OCT, vitreous opacity (“W-OCT VO”) and the presence of vitreous cells (“W-OCT Cells”) were identified by three specialists. We compared findings from ophthalmoscopy (“Ophthalmoscopic findings”) and fluorescein angiography (“FAG findings”) with those from W-OCT.

Results

This study investigated 132 eyes from 68 patients (34 males, 34 females; mean age, 53.97±22.71 years). Vitreous cells in posterior uveitis and panuveitis differed significantly between “W-OCT Cells” and “Ophthalmoscopic findings” for all cases (P = 0.00014). Vitreous opacities in posterior uveitis and panuveitis did not differ significantly between “W-OCT VO” and “Ophthalmoscopic findings” (P = 0.144) for all cases. Compared to “Ophthalmoscopic findings”, “W-OCT Cells” offered 51.1% sensitivity and 66.7% specificity for all cases (p<0.01). Compared to “Ophthalmoscopic findings”, “W-OCT VO” offered 78.6% sensitivity and 30% specificity for all cases (p = 0.19). In addition, “W-OCT Cells” did not differ significantly from “FAG findings” for all cases (P = 0.424).

Conclusion

W-OCT was shown to offer significantly greater sensitivity than ophthalmoscopy for detecting vitreous cells. The results of this study may add an option for the evaluation of uveitis.

Introduction

Uveitis is an inflammatory disease that threatens sight worldwide [1]. The annual number of new cases of uveitis is reportedly 17–52 per 100,000 persons [24]. The quantification of inflammatory findings has been used to diagnose uveitis since 1959 [5]. The diagnosis of uveitis also requires a physical examination and serological tests [6]. A variety of tests are available, however standardizing testing methods will lower the cost of testing [7]. Tests that can be standardized are therefore important. In recent years, "The SUN* Working Group Grading Scheme for Anterior Chamber Cells" scale [8] defined by the SUN Working Group are often used. This scale allows the quantification of ophthalmoscopic findings.

In ophthalmology, ophthalmoscopy is a fundamental examination. The technology of ophthalmic diagnosis has evolved due to the appearance of optical coherence tomography (OCT). In uveitis, OCT allows the identification of changes in retinal shape such as macular edema [9]. OCT is an imaging modality that also allows objective evaluation through analysis. However, from the perspective of technical feasibility, issues such as examination time mean that OCT can only evaluate a portion of the retina, such as the macula. Technological developments have increased the scanning speed of OCT and have thus allowed scanning of a wider angle. In the past, OCT has been reported to allow direct visualization of vitreous inflammatory cells in patients with uveitis [10]. However, such evaluations have only been performed for the macular area. The Xephilio OCT-S1 (Canon, Tokyo, Japan) is an ultra-widefield OCT platform. The present study aimed to evaluate vitreous inflammation not only in the macula, however also in a wider area using wide-angle OCT (W-OCT).

While OCT allows evaluations that were previously unavailable, the method is not perfect. As a result, assessments must be made by combining a variety of tests. For example, the rapid kit for influenza offers a reported sensitivity of 27% and specificity of 97% [11]. When the sensitivity is low, diagnoses are made based on other tests and medical conditions. Ophthalmoscopy is the basis of examinations of the eye. However, it could be difficult to perform in some cases. OCT is an advanced examination and is thought to provide stable results in some difficult case.

Artificial intelligence (AI) is therefore being utilized in the identification of diseases including macular degeneration [12,13]. Automated analysis of results from OCT may allow more accurate diagnosis in the future. No reports appear to have described the sensitivity and specificity of W-OCT for identifying uveitis. This study therefore investigated the sensitivity and specificity of "Ophthalmoscopic findings" and "W-OCT" findings.

Materials and methods

Data collection

This retrospective study included patients who visited the Ocular Inflammation and Tumor Outpatient Clinic at Osaka Metropolitan University. Patients included in this study were from January 2019 to January 2022. All patients had been diagnosed with uveitis and had undergone W-OCT. Descriptions of anterior chamber inflammation and vitreous inflammation were extracted from Ophthalmoscopic findings. Inflammation results were based on the presence or absence of inflammatory cells. The existence of inflammatory cells (“Cells”) and vitreous opacity (“VO”) was determined by W-OCT. Wide-angle fluorescein angiography was also performed, with the results defined as “FAG findings”. “cells” were defined as hyperreflective dots that were larger and greater density than noise in background [14]. "Vitreous opacity” were defined as hyperreflective area in background” Fig 1”. Inflammatory findings such as vasculitis and pigment epitheliitis were examined under fluorescein angiography. Fluorescein angiography was performed using a TRC-50DX (Topcon, Tokyo, Japan), Heidelberg Spectralis-OCT2 (Heidelberg Engineering, Heidelberg, Germany) or Optos 200Tx (Optos PLC, Dunfermline, Scotland) system. Each judgment was made as the consensus decision of three doctors (N.M, A.S, and M.T) in a specialized outpatient clinic. In cases of discrepancies, decision was made by consultation with S.H. The Xephilio OCT-S1 (Canon) is a swept-source W-OCT system that can capture 78° horizontal and 68° vertical. Tracking was used for the examination, and a wide-area imaging mode was used.

Fig 1.

Fig 1

(A) Many cells are observed in the vitreous cavity. White arrow. (B) Enlarged image of (A). Magnify 2x. (C) Large vitreous opacity is seen in the vitreous cavity. White arrowhead. (D) Enlarged image of (C). Magnify 2x.

We obtained consent from all patients. This study complied with the principles of the Declaration of Helsinki and was approved by the Ethics Review Committee of Osaka Metropolitan University (approval no. 2019–062). For minors, consent must be obtained from a parent or guardian.

Statistical analysis

Sensitivity and specificity were calculated. Patient characteristics were summarized using descriptive statistics for quartiles and percentages, and the χ2 test was used for comparisons. McNemar’s test was performed for the comparison of inflammatory findings. Statistical analyses were performed using SPSS Statistics version 22 software (IBM Japan, Tokyo, Japan). Values of P < 0.05 were considered statistically significant.

Results

Characteristics

In total, 132 eyes from 68 patients were included in the study “Table 1”. The enrolled patients comprised 34 males and 34 females, with a mean age of 53.97±22.71years (range, 6–87 years). A detailed distribution of the 132 eyes is shown in “Table 1”. Uveitis was the most frequently registered vitreous cells (54.5%), with no identified cause in any case. Sarcoidosis (12.1%) and Vogt-Koyanagi-Harada syndrome (VKH) (13.6%) were also common. Infectious uveitis was diagnosed by blood sampling and PCR (polymerase chain reaction) testing of anterior chamber fluid and vitreous fluid. Patient characteristics were analyzed by posterior inflammation examination “Table 2”. IOP (intra ocular pressure) (p = 0.026) and age were significantly lower in patients in whom cells were present (p = 0.006). In “FAG findings”, significant differences in IOP (p = 0.022) and age (p = 0.013) were seen between patients with and without inflammation.

Table 1. Characteristics of all patients.

IOP, ES, and age are shown as median and quartiles and were compared using the χ2 test.

Factor Group n (%)
W-OCT Cells None 60 (45.5)
Cells present 72 (54.5)
W-OCT VO None 102 (77.3)
VO present 30 (22.7)
Ophthalmoscopic findings: Cells None 90 (68.2)
Cells present 42 (31.8)
Ophthalmoscopic findings: VO None 112 (84.8)
VO present 20 (15.2)
FAG findings None 30 (37.5)
Inflammation present 50 (62.5)
Eye Right 66 (50.0)
Left 66 (50.0)
Sex Male 45 (51.1)
Female 43 (48.9)
Disease Acute retinal necrosis 4 (3.0)
Behcet disease 2 (1.5)
Cytomegalovirus 2 (1.5)
HTLV-1 2 (1.5)
Sarcoidosis 16 (12.1)
Syphilis 10 (7.6)
Uveitis 72 (54.5)
VKH 18 (13.6)
Scleritis 4 (3.0)
Sympathetic uveitis 2 (1.5)
Median [quartiles]
Intraocular pressure (IOP) 13.00 [11.00, 15.00]
Equivalent sphere (ES) -0.75 [-2.25, 0.25]
Age, years 57.50 [37.00, 72.25]

VO: vitreous opacity, VKH: Vogt-Koyanagi-Harada syndrome.

Table 2. Characteristics by examination.

IOP, ES, and age are shown as median and quartiles. Statistical comparisons were performed using the χ2 test. Significant differences in IOP and ES were observed between W-OCT and FAG findings.

Ophthalmoscopic findings: Cells W-OCT Cells FAG findings
None or Present None Cells present p-value None Cells present p-value None Inflammation present p-value
n 90 42 60 72 30 50
Eye (%) Right 43 (47.8) 23 (54.8) 0.575 30 (50.0) 36 (50.0) 1 14 (46.7) 26 (52.0) 0.818
Left 47 (52.2) 19 (45.2) 30 (50.0) 36 (50.0) 16 (53.3) 24 (48.0)
Sex, n (%) Male 31 (51.7) 14 (50.0) 1 16 (40.0) 29 (60.4) 0.086 14 (66.7) 17 (50.0) 0.272
Female 29 (48.3) 14 (50.0) 24 (60.0) 19 (39.6) 7 (33.3) 17 (50.0)

Disease, n (%)
Acute retinal necrosis 3 (3.3) 1 (2.4) 1 (1.7) 3 (4.2) 2 (6.7) 2 (4.0)
Behcet disease 0 (0.0) 2 (4.8) 0 (0.0) 2 (2.8) 0 (0.0) 2 (4.0)
Cytomegalovirus 1 (1.1) 1 (2.4) 1 (1.7) 1 (1.4) 0 (0.0) 0 (0.0)
HTLV-1 2 (2.2) 0 (0.0) 0 (0.0) 2 (2.8) 0 (0.0) 0 (0.0)
Sarcoidosis 10 (11.1) 6 (14.3) 14 (23.3) 2 (2.8) 2 (6.7) 6 (12.0)
Syphilis 5 (5.6) 5 (11.9) 2 (3.3) 8 (11.1) 5 (16.7) 3 (6.0)
Uveitis 46 (51.1) 26 (61.9) 35 (58.3) 37 (51.4) 13 (43.3) 27 (54.0)
VKH 17 (18.9) 1 (2.4) 4 (6.7) 14 (19.4) 5 (16.7) 9 (18.0)
Scleritis 4 (4.4) 0 (0.0) 3 (5.0) 1 (1.4) 2 (6.7) 0 (0.0)
Sympathetic uveitis 2 (2.2) 0 (0.0) 0 (0.0) 2 (2.8) 1 (3.3) 1 (2.0)
Intraocular pressure (IOP) 13.50 [11.00, 15.00] 13.00 [11.00, 14.75] 0.536 14.00 [12.00, 16.00] 13.00 [11.00, 14.00] 0.026* 13.50 [12.00, 15.00] 12.00 [10.00, 14.00] 0.022*
Equivalent sphere (ES) -0.50 [-2.19, 0.47] -1.19 [-2.25, 0.12] 0.235 -0.50 [-2.31, 0.28] -0.94 [-2.25, 0.25] 0.609 -0.32 [-2.81, 0.84] -1.44 [-4.06, -0.25] 0.055
Age, years 58.00 [45.75, 70.25] 55.00 [31.75, 73.25] 0.764 65.50 [52.75, 78.25] 54.00 [30.25, 65.00] 0.006* 65.00 [56.00, 78.00] 52.50 [32.75, 65.75] 0.013*

Relation to severity of uveitis

We examined the good and poor vision groups. The good visual acuity group was defined as LogMAR less than or equal to 0. The poor group was defined as greater than 0. There was no significant difference between the presence or absence of cells on W-OCT in both the good visual acuity and poor visual acuity groups(p = 0.888,0.511).

Similarly, there was no significant difference in VO on W-OCT between the good and poor visual acuity groups(p = 0.683,0.633).

Sensitivity and specificity

Compared with “Ophthalmoscopic findings”, for all cases “Table 3A”, “W-OCT Cells” offered 51.1% sensitivity and 66.7% specificity, with detection of vitreous cells in posterior uveitis and panuveitis differing significantly (p = 0.00014). In panuveitis “Table 3B”, “W-OCT Cells” offered 44.7% sensitivity and 68.8% specificity, again showing a significant difference compared to ophthalmoscopy (p = 0.00326).

Table 3. a) Sensitivity and specificity compared to ophthalmoscopy in all cases.

b) Sensitivity and specificity for panuveitis cases. c) Sensitivity and specificity of "W-OCT Cells" compared to fluorescence for all cases and panuveitis.

All cases
Examination Sensitivity (%) Specificity (%) AUC Positive likelihood ratio Negative likelihood ratio p-value
W-OCT Cells 51.1 66.7 0.531 1.533 0.733 0.00014
W-OCT VO 78.6 30 0.578 1.122 0.714 0.144
FAG findings 52.9 89.7 0.71 5.118 0.525 0.000119
b)
Panuveitis
Examination Sensitivity (%) Specificity (%) AUC Positive likelihood ratio Negative likelihood ratio p-value
W-OCT Cells 44.7 68.8 0.558 1.432 0.804 0.00326
W-OCT VO 68.2 30 0.494 0.974 1.061 0.19
FAG findings 53.8 91.7 0.706 6.462 0.503 0.00555
c)
W-OCT Cells v.s. FAG findings
Examination Sensitivity (%) Specificity (%) AUC Positive likelihood ratio Negative likelihood ratio p-value
All cases 66.7 70 0.675 2.222 0.476 0.424
Panuveitis 53.3 78.3 0.668 2.453 0.598 0.773

Compared to “Ophthalmoscopic findings”, for all cases “Table 3A”, “W-OCT VO” offered 78.6% sensitivity and 30% specificity, showing no significant difference (p = 0.144) in the detection of vitreous opacity. For panuveitis “Table 3B”, sensitivity was 68.2% and specificity was 30%, showing no significant difference (p = 0.19).

Comparing “W-OCT Cells” and “FAG findings”, for all cases “Table 3C”, sensitivity was 66.7% and specificity was 70%, showing no significant difference (p = 0.424). In panuveitis “Table 3C”, sensitivity was 53.3% and specificity was 78.3%, showing no significant difference (p = 0.773).

Discussion

"W-OCT Cells" showed low sensitivity and high specificity compared to “Ophthalmoscopic findings”. Observing inflammatory cells in the near retina is difficult under ophthalmoscopy in normal practice. Even the smallest inflammatory cells are recorded by W-OCT, which is considered highly specific. However, W-OCT is considered more sensitive because it detects inflammation that is not apparent under ophthalmoscopy. OCT is more accurate than ophthalmoscopy for measurement because an objective assessment can be provided [15]. The present study showed that W-OCT may be more sensitive to inflammation than ophthalmoscopy. W-OCT can scan a wide area of retina, however does not capture the whole vitreous cavity. In anterior vitreous inflammation cases, OCT are easily identified by ophthalmoscopy in all cases.

This difference may have contributed to the significant differences in posterior inflammation. In other hands, pan uveitis may be easier to evaluate with W-OCT because of the wide range of inflammation. Therefore, if only cases of pan uveitis are examined, inflammatory cells may be detected better than ophthalmoscopic findings.

In addition, W-OCT Cells and FAG findings showed no significant difference in identifying in all cases and pan uveitis in Table 3C). This result suggested that FAG could be assessed retinal inflammation, which might not reflect posterior vitreous cavity inflammation.

In pan uveitis, inflammation is seen throughout the entire area, which may have reduced discrepancies by location. In some diseases, such as pan uveitis, W-OCT may be able to assess intraocular inflammation.

In terms of patient background characteristics, both "W-OCT Cells" and "FAG findings" showed significant differences according to IOP and age. Both groups with inflammation were younger with significantly lower IOP. In this study, "W-OCT cells" showed low sensitivity and high specificity, suggesting that some inflammatory findings may not be detected by W-OCT. In all cases, W-OCT and FAG findings were significantly different compared to ophthalmoscopic findings. This could represent bias due to the cases tested in this study.

A previous report described sarcoidosis as the most common cause of uveitis in Japan [16]. In our study, however, VKH was slightly more common than sarcoidosis. This may be due to the small overall number of participants and because W-OCT was not performed for all patients, resulting in bias. In Behcet’s disease, both Cells and VO were observed in all test groups. This may be a result of the high prevalence of Behcet’s disease, which could have been detected in all the tests. On the other hand, HTLV-1 cells were not observed as "Ophthalmoscopic findings" however were observed by "W-OCT". This suggests that W-OCT may be able to detect slight inflammation that cannot be detected by ophthalmoscopy. W-OCT allows direct recording of inflammatory cells, including on the periphery. Therefore, new disease names and classifications may be added in the future.

IOP was lower when W-OCT detected cells, however this was not observed when "Ophthalmoscopic findings" detected cells. Uveitis is known to increase IOP [17], however the underlying mechanisms are variable. On the other hand, inflammation in the eye decreases aqueous humor production, reducing IOP [18]. "W-OCT cells" group found significant IOP lowering, however not in "Ophthalmoscopic findings" group. W-OCT may capture inflammation more acutely than ophthalmoscopic findings in Table 2. In particular, W-OCT may capture inflammation in a wider area around the retina than can be observed with OCT. Therefore, it is possible that there is a significant difference due to the selection of a more inflammatory group. Almost all of the present cases were examined at the time of initial examination, and changes in corner angles thus may not yet have occurred due to the short duration of the disease.

OCT has become an important part of medical practice in dealing with uveitis [19,20]. In recent years, various methods have been reported to quantify uveitis [21,22]. However, past reports have been evaluated using OCT of the macula only. Laser flare photometry is useful for assessing inflammation in the anterior chamber [23]. Schalnus reported that anterior-chamber inflammation in laser flare relates to anterior uveitis [24], however not to posterior uveitis. The present study found no notable differences in sensitivity or specificity between all cases and cases with panuveitis. More recently, AI analyses have been conducted using OCT [25]. Since findings of inflammation can be stored in OCT data, further advances may be made by AI using deep learning for W-OCT images. Combining ophthalmoscopic findings with W-OCT may allow evaluation of inflammation in uveitis from anterior uveitis to posterior uveitis.

Fluorescein angiography also plays an important role in the diagnosis of uveitis [26]. Wide-angle examination is also important in fluorescein angiography [27]. In this study, no significant difference in findings was seen between "W-OCT" and "FAG findings". In anterior uveitis, fluorescence examinations are also useful [28], and anterior uveitis may also show inflammation in the vicinity of the retina. In the future, W-OCT could be used to evaluate peripheral retinal inflammation instead of fluorescence.

In terms of VO, sensitivity was high and specificity was low for both all cases and panuveitis cases. VO can be localized, and many cases were not identified by W-OCT. VO was also present in a small number of cases. For these reasons, VO showed no significant difference between ophthalmoscopy and W-OCT. Future improvements in imaging accuracy may make VO evaluation more accurate and quantifiable. If VO can be accurately quantified, the intraocular inflammatory state and components of VO may be discernible.

“W-OCT” and “FAG findings” showed that patients with inflammation tended to have lower IOP and were younger. In uveitis, IOP is increased [29]. In normal eyes, IOP increases with age in populations from Europe [30] and the United States, however decreases in Japanese populations [31]. IOP is affected by a variety of factors, including refractive index and blood pressure [32]. Younger patients may be more sensitive to inflammation, and factors other than age may also contribute to lower IOP.

Limitations

All participants in this study were Japanese, so effect of ethnicity cannot be ruled out. The study cohort was small, because few patients had undergone W-OCT. Due to the high scanning speed of W-OCT, different objects may potentially be captured and misidentified as cells. It has been reported that OCT in the anterior segment optical coherence tomography can reclassify artifacts as cells [33]. Therefore, it is possible that the artifacts may be used to identify cells in this study as well in W-OCT. This may be due to OCT image blurring by cataracts [34]. W-OCT can evaluate retinal conditions from the posterior vitreous. However, it cannot evaluate the anterior vitreous state. Since OCT images are affected by anterior chamber conditions, W-OCT evaluation may differ due to inflammation or cataracts in the anterior vitreous [35].

Conclusions

W-OCT may be superior to ophthalmoscopy in detecting vitreous cells in uveitis. W-OCT alone has the potential to determine the severity and diagnosis of uveitis. With the development of future analytical programs, sensitivity and specificity may increase over ophthalmoscopic findings. W-OCT also showed similar acquisition of inflammatory findings compared to FAG. Therefore, intraocular inflammation may be assessable by W-OCT instead of FAG. W-OCT is an objective, reproducible method as a machine evaluation. W-OCT may create a new standard for assessing the status of intraocular inflammation.

Supporting information

S1 File

(XLSX)

Acknowledgments

We are grateful to Sentaro Kusuhara, M.D., Ph.D., for his writing advice.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–17. Epub 20130503. doi: 10.5301/ejo.5000278 . [DOI] [PubMed] [Google Scholar]
  • 2.Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005;45(2):1–13. doi: 10.1097/01.iio.0000155938.83083.94 . [DOI] [PubMed] [Google Scholar]
  • 3.Rothova A, Suttorp-Van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. British Journal of Ophthalmology. 1996;80(4):332–6. doi: 10.1136/bjo.80.4.332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol. 1962;68:502–14. doi: 10.1001/archopht.1962.00960030506014 . [DOI] [PubMed] [Google Scholar]
  • 5.Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959;47(5 Pt 2):155–70. doi: 10.1016/s0002-9394(14)78239-x . [DOI] [PubMed] [Google Scholar]
  • 6.Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, et al. Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmunity Reviews. 2017;16(12):1254–64. doi: 10.1016/j.autrev.2017.10.010 [DOI] [PubMed] [Google Scholar]
  • 7.De Parisot A, Jamilloux Y, Kodjikian L, Errera M-H, Sedira N, Heron E, et al. Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study). PLOS ONE. 2020;15(2):e0228918. doi: 10.1371/journal.pone.0228918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–16. doi: 10.1016/j.ajo.2005.03.057 ; PubMed Central PMCID: PMC8935739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, Foster CS. The characteristic features of optical coherence tomography in posterior uveitis. British Journal of Ophthalmology. 2007;91(12):1680–5. doi: 10.1136/bjo.2007.124099 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Saito M, Barbazetto IA, Spaide RF. INTRAVITREAL CELLULAR INFILTRATE IMAGED AS PUNCTATE SPOTS BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN EYES WITH POSTERIOR SEGMENT INFLAMMATORY DISEASE. RETINA. 2013;33(3):559–65. doi: 10.1097/IAE.0b013e31826710ea 00006982-201303000-00013. [DOI] [PubMed] [Google Scholar]
  • 11.Stebbins S, Stark JH, Prasad R, Thompson WW, Mitruka K, Rinaldo C, et al. Sensitivity and specificity of rapid influenza testing of children in a community setting1. Influenza and Other Respiratory Viruses. 2011;5(2):104–9. doi: 10.1111/j.1750-2659.2010.00171.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Waldstein SM, Vogl W-D, Bogunovic H, Sadeghipour A, Riedl S, Schmidt-Erfurth U. Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography. JAMA Ophthalmology. 2020;138(7):740. doi: 10.1001/jamaophthalmol.2020.1376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lee CS, Tyring AJ, Wu Y, Xiao S, Rokem AS, Deruyter NP, et al. Generating retinal flow maps from structural optical coherence tomography with artificial intelligence. Scientific Reports. 2019;9(1). doi: 10.1038/s41598-019-42042-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Keane PA, Karampelas M, Sim DA, Sadda SR, Tufail A, Sen HN, et al. Objective Measurement of Vitreous Inflammation Using Optical Coherence Tomography. Ophthalmology. 2014;121(9):1706–14. doi: 10.1016/j.ophtha.2014.03.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Amedo AO, Koomson NY, Kobia Acquah E, Pascal TM, Atuahene J, Akowuah PK, et al. Comparison of the clinical estimation of cup-to-disk ratio by direct ophthalmoscopy and optical coherence tomography. Therapeutic Advances in Ophthalmology. 2019;11:251584141982726. doi: 10.1177/2515841419827268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sonoda K-H, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Japanese Journal of Ophthalmology. 2021;65(2):184–90. doi: 10.1007/s10384-020-00809-1 [DOI] [PubMed] [Google Scholar]
  • 17.Din NM, Isa H, Taylor SR, Barton K, Lightman SL. Intraocular pressure elevation in uveitis. Expert Review of Ophthalmology. 2012;7(1):45–59. doi: 10.1586/eop.11.75 [DOI] [Google Scholar]
  • 18.Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28(3):477–81. . [PubMed] [Google Scholar]
  • 19.Karampelas M, Sim DA, Keane PA, Zarranz-Ventura J, Patel PJ, Tufail A, et al. Choroidal assessment in idiopathic panuveitis using optical coherence tomography. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2013;251(8):2029–36. doi: 10.1007/s00417-013-2330-7 [DOI] [PubMed] [Google Scholar]
  • 20.Keane PA, Allie M, Turner SJ, Southworth HS, Sadda SR, Murray PI, et al. Characterization of Birdshot Chorioretinopathy Using Extramacular Enhanced Depth Optical Coherence Tomography. JAMA Ophthalmology. 2013;131(3):341. doi: 10.1001/jamaophthalmol.2013.1724 [DOI] [PubMed] [Google Scholar]
  • 21.Agrawal R, Salman M, Tan K-A, Karampelas M, Sim DA, Keane PA, et al. Choroidal Vascularity Index (CVI)—A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis? PLOS ONE. 2016;11(1):e0146344. doi: 10.1371/journal.pone.0146344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Liu X, Kale AU, Ometto G, Montesano G, Sitch AJ, Capewell N, et al. OCT Assisted Quantification of Vitreous Inflammation in Uveitis. Translational Vision Science & Technology. 2022;11(1):3. doi: 10.1167/tvst.11.1.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. International Ophthalmology. 2010;30(5):453–64. doi: 10.1007/s10792-009-9310-2 [DOI] [PubMed] [Google Scholar]
  • 24.Schalnus RW, Ohrloff C. Comparative laser flare measurement and fluorophotometry in anterior and posterior uveitis. Der Ophthalmologe. 1998;95(1):3–7. doi: 10.1007/s003470050227 [DOI] [PubMed] [Google Scholar]
  • 25.Kapoor R, Whigham BT, Al-Aswad LA. Artificial Intelligence and Optical Coherence Tomography Imaging. The Asia-Pacific Journal of Ophthalmology. 2019;8(2):187–94. doi: 10.22608/APO.201904 -201903000-00012. [DOI] [PubMed] [Google Scholar]
  • 26.Hong BK, Nazari Khanamiri H, Rao NA. Role of ultra-widefield fluorescein angiography in the management of uveitis. Can J Ophthalmol. 2013;48(6):489–93. doi: 10.1016/j.jcjo.2013.05.009 . [DOI] [PubMed] [Google Scholar]
  • 27.Campbell JP, Leder HA, Sepah YJ, Gan T, Dunn JP, Hatef E, et al. Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol. 2012;154(5):908–11 e2. Epub 20120828. doi: 10.1016/j.ajo.2012.05.019 . [DOI] [PubMed] [Google Scholar]
  • 28.Chi Y, Guo C, Peng Y, Qiao L, Yang L. A Prospective, Observational Study on the Application of Ultra-Wide-Field Angiography in the Evaluation and Management of Patients with Anterior Uveitis. PLOS ONE. 2015;10(3):e0122749. doi: 10.1371/journal.pone.0122749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, et al. Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. Ophthalmology. 2017;124(8):1196–208. doi: 10.1016/j.ophtha.2017.03.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Colton T, Ederer F. The distribution of intraocular pressures in the general population. Surv Ophthalmol. 1980;25(3):123–9. doi: 10.1016/0039-6257(80)90086-7 . [DOI] [PubMed] [Google Scholar]
  • 31.Nomura H, Shimokata H, Ando F, Miyake Y, Kuzuya F. Age-related changes in intraocular pressure in a large Japanese population: a cross-sectional and longitudinal study. Ophthalmology. 1999;106(10):2016–22. doi: 10.1016/S0161-6420(99)90417-7 . [DOI] [PubMed] [Google Scholar]
  • 32.Nakano T, Tatemichi M, Miura Y, Sugita M, Kitahara K. Long-term physiologic changes of intraocular pressure: a 10-year longitudinal analysis in young and middle-aged Japanese men. Ophthalmology. 2005;112(4):609–16. doi: 10.1016/j.ophtha.2004.10.046 . [DOI] [PubMed] [Google Scholar]
  • 33.Igbre AO, Rico MC, Garg SJ. HIGH-SPEED OPTICAL COHERENCE TOMOGRAPHY AS A RELIABLE ADJUVANT TOOL TO GRADE OCULAR ANTERIOR CHAMBER INFLAMMATION. Retina. 2014;34(3):504–8. doi: 10.1097/IAE.0b013e31829f73bd [DOI] [PubMed] [Google Scholar]
  • 34.Van Velthoven MEJ. Influence of cataract on optical coherence tomography image quality and retinal thickness. British Journal of Ophthalmology. 2006;90(10):1259–62. doi: 10.1136/bjo.2004.097022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Yu S, Frueh BE, Steinmair D, Ebneter A, Wolf S, Zinkernagel MS, et al. Cataract significantly influences quantitative measurements on swept-source optical coherence tomography angiography imaging. PLOS ONE. 2018;13(10):e0204501. doi: 10.1371/journal.pone.0204501 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

De-Kuang Hwang

8 Jan 2023

PONE-D-22-28716Relationship between ultra-widefield optical coherence tomography and ophthalmoscopy for detecting posterior inflammation in posterior uveitis and panuveitisPLOS ONE

Dear Dr. Tagami,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

De-Kuang Hwang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent.

3. Thank you for stating the following financial disclosure:

“No”

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in your Competing Interests section: 

“no competing interests”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

1. please provide explain the definition of "cells" and "vitreous opacity" in W-OCT in Method.

2. please provide figure(s) to demonstrate the vitreous cells and vitreous opacity in W-OCT.

3. is there any correlation between "amount of vitreous cells" and "degree of vitreous opacity" in W-OCT, and clinical severity of uveitis?

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. line 73: 2 comma

2. line 197: Uveitis is known to increase IOP due to clogging of the trabecular meshwork with inflammatory cells, trabeculitis, pupillary block, synechial closure or secondary to steroid usage. However, decrease aqueous humor production may cause lower IOP initially. Lower IOP was observed in “W-OCT cells” group, yet was not observed in "Ophthalmoscopic findings " detected cells group. Try to clarify the reasons or mechanism in discussion.

3. line 206: They reported that anterior-chamber inflammation… Please list the author’s name.

Reviewer #2: Line 73: “Ophthalmoscopy is the basis of examinations of the eye, , could be difficult to be performed in some cases”. Please change to “Ophthalmoscopy is the basis of examinations of the eye. However, it could be difficult to perform in some cases.”

Line 86: “Patients were included in this study from January 2019 to January 2022.”, Please change to “Patients included in this study were from January 2019 to January 2022.”

Line 99: “decision was made by consultation S.H.” Please change to “decision was made by consultation with S.H.”

Line 124: Please change “Cells” to “cells”.

Line 135: Please correct the spelling of “Fluorescenc”

Line 173: The authors stated that “For identifying panuveitis, no significant difference existed between ophthalmoscopy and W-OCT.” Yet in line 145, the author stated in panuveitis (Table 3b), “W-OCT Cells” offered 44.7% sensitivity and 68.8% specificity, again showing a significant difference compared to ophthalmoscopy. Please explain the seemingly contradictory statements.

Please state and explain the likelihood of OCT misclassifying artifacts as cells either in this study or citing from other studies.

Since W-OCT cannot assess cells in the anterior chamber, W-OCT may be more of a tool used for posterior uveitis, instead of panuveitis, as a strong anterior chamber inflammation may introduce significant artifacts into posterior cells evaluation. You may need to include this statement in your limitations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer Attachments for Manuscript Number PONE-D-22-28716.docx

PLoS One. 2023 Feb 10;18(2):e0281714. doi: 10.1371/journal.pone.0281714.r002

Author response to Decision Letter 0


27 Jan 2023

Additional Editor Comments:

1. please provide explain the definition of "cells" and "vitreous opacity" in W-OCT in Method.

P6 L91

“cells” were defined as hyperreflective dots that were larger and greater density than noise in background [14] . "vitreous opacity” were defined as hyperreflective area in background” Figure1”.

We added the above to the method article. Thank you for pointing out this critical part. Appreciate your advice greatly.

2. please provide figure(s) to demonstrate the vitreous cells and vitreous opacity in W-OCT.

P8L117

Figure1

(A) Many cells are observed in the vitreous cavity. White arrow.

(B) Enlarged image of (A). Magnify 2x.

(C) Large vitreous opacity is seen in the vitreous cavity. White arrowhead.

(D) Enlarged image of (C). Magnify 2x.

We added figure to the method article. Thank you for your advice.

3. is there any correlation between "amount of vitreous cells" and "degree of vitreous opacity" in W-OCT, and clinical severity of uveitis?

P15 L162

Relation to severity of uveitis

We examined the good and poor vision groups. The good visual acuity group was defined as LogMAR less than or equal to 0. The poor group was defined as greater than 0. There was no significant difference between the presence or absence of cells on W-OCT in both the good visual acuity and poor visual acuity groups(p=0.888,0.511).

Similarly, there was no significant difference in VO on W-OCT between the good and poor visual acuity groups(p=0.683,0.633).

W-OCT can scan deep and wide areas quickly. However, it is difficult to compare the same location between patients, especially for the vitreous cavity. Also, because the scan is fast, more cells can be detected.So, accurate measurement of the cell number was difficult. Therefore, cell count and degree of vitreous opacity was not performed. The good vision group and the poor vision group were examined.No association was found with the presence or absence of cells or vitreous opacity.

There was no significant difference from clinical severity of uveitis.

We added figure to theresult article. Thank you for your advice.

Reviewer #1:

1. line 73: 2 comma

P5L72

Ophthalmoscopy is the basis of examinations of the eye.

Mistakes have been corrected. Thanks for pointing out the details.

2. line 197: Uveitis is known to increase IOP due to clogging of the trabecular meshwork with inflammatory cells, trabeculitis, pupillary block, synechial closure or secondary to steroid usage. However, decrease aqueous humor production may cause lower IOP initially. Lower IOP was observed in “W-OCT cells” group, yet was not observed in "Ophthalmoscopic findings " detected cells group. Try to clarify the reasons or mechanism in discussion.

P19L235

"W-OCT cells" group found significant IOP lowering, however not in "Ophthalmoscopic findings" group. W-OCT may capture inflammation more acutely than ophthalmoscopic findings in table2. In particular, W-OCT may capture inflammation in a wider area around the retina than can be observed with OCT. Therefore, it is possible that there is a significant difference due to the selection of a more inflammatory group.

We added the above to the discussion article. Thank you for your advice.

3. line 206: They reported that anterior-chamber inflammation… Please list the author’s name.

P20L246

Schalnus reported that anterior-chamber inflammation in laser flare relates to anterior uveitis[24], however not to posterior uveitis.

Changed citation location and subject text. Thank you for pointing out the difficult to understand part.

Reviewer #2:

Line 73: “Ophthalmoscopy is the basis of examinations of the eye, , could be difficult to be performed in some cases”. Please change to “Ophthalmoscopy is the basis of examinations of the eye. However, it could be difficult to perform in some cases.”

Line 86: “Patients were included in this study from January 2019 to January 2022.”, Please change to “Patients included in this study were from January 2019 to January 2022.”

Line 99: “decision was made by consultation S.H.” Please change to “decision was made by consultation with S.H.”

Line 124: Please change “Cells” to “cells”.

Line 135: Please correct the spelling of “Fluorescenc”

P5L72

Ophthalmoscopy is the basis of examinations of the eye. However, it could be difficult to perform in some cases.

P6L84

Patients included in this study were from January 2019 to January 2022.

P6L98

In cases of discrepancies, decision was made by consultation with S.H.

P10L139

patients in whom cells were present (p=0.006).

P13L150

Significant differences in IOP and ES were observed between W-OCT and FAG findings.

Thanks for pointing that out. I have corrected the error.

Line 173: The authors stated that “For identifying panuveitis, no significant difference existed between ophthalmoscopy and W-OCT.” Yet in line 145, the author stated in panuveitis (Table 3b), “W-OCT Cells” offered 44.7% sensitivity and 68.8% specificity, again showing a significant difference compared to ophthalmoscopy. Please explain the seemingly contradictory statements.

P18L201

In anterior vitreous inflammation cases, OCT are easily identified by ophthalmoscopy in all cases.

This difference may have contributed to the significant differences in posterior inflammation. In other hands, pan uveitis may be easier to evaluate with W-OCT because of the wide range of inflammation. Therefore, if only cases of pan uveitis are examined, inflammatory cells may be detected better than ophthalmoscopic findings.

In addition, W-OCT Cells and FAG findings showed no significant difference in identifying in all cases and pan uveitis in table 3C). This result suggested that FAG could be assessed retinal inflammation, which might not reflect posterior vitreous cavity inflammation.

We added the above to the discussion article. Thank you for your advice.

Please state and explain the likelihood of OCT misclassifying artifacts as cells either in this study or citing from other studies.

P22L279

It has been reported that OCT in the anterior segment optical coherence tomography can reclassify artifacts as cells [33]. Therefore, it is possible that the artifacts may be used to identify cells in this study as well in W-OCT.

We added the above to the limitation article. Thank you for your advice.

Since W-OCT cannot assess cells in the anterior chamber, W-OCT may be more of a tool used for posterior uveitis, instead of panuveitis, as a strong anterior chamber inflammation may introduce significant artifacts into posterior cells evaluation. You may need to include this statement in your limitations.

P22L282

W-OCT can evaluate retinal conditions from the posterior vitreous. However, it cannot evaluate the anterior vitreous state. Since OCT images are affected by anterior chamber conditions, W-OCT evaluation may differ due to inflammation or cataracts in the anterior vitreous [35].

We added the above to the limitation article. Thank you for your advice.

Attachment

Submitted filename: renamed_75a39.docx

Decision Letter 1

De-Kuang Hwang

31 Jan 2023

Relationship between ultra-widefield optical coherence tomography and ophthalmoscopy for detecting posterior inflammation in posterior uveitis and panuveitis

PONE-D-22-28716R1

Dear Dr. Tagami,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

De-Kuang Hwang

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

De-Kuang Hwang

2 Feb 2023

PONE-D-22-28716R1

Relationship between ultra-widefield optical coherence tomography and ophthalmoscopy for detecting posterior inflammation in posterior uveitis and panuveitis

Dear Dr. Tagami:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. De-Kuang Hwang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (XLSX)

    Attachment

    Submitted filename: Reviewer Attachments for Manuscript Number PONE-D-22-28716.docx

    Attachment

    Submitted filename: renamed_75a39.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES